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Abstract 
 
Continuous-flow systems have emerged as a powerful technology for performing chemical transformations and have 
recently attracted attention also for the preparation of chiral APIs (active pharmaceutical ingredients).[1] 
 
Recently developed stereoselective transformations performed in chiral organocatalytic reactors under continuous 
flow conditions will be presented. Both packed-bed and monolithic reactors, either made by silica and/or organic 
polymers, have been successfully used in metal-free reactions promoted by immobilized enantiopure primary or 
secondary amines.[2] 
The possibility to perform organocatalytic reactions in (micro)-mesoreactors and to synthesize in flow-mode chiral 
intermediates of pharmaceutical interest will be also discussed.[3] 
 
On the other hand, 3D-printing technology allows chemists to build devices with high precision and well-defined 
architecture. Stereoselective catalytic in-flow reactions in 3D-printed reactors will be also briefly highlighted.[4] 
The combination of these two only partially explored technologies in stereoselective organic synthesis opens new 
and intriguing possibilities; the fabrication of ad hoc designed reactors and other devices, to perform at best different 
reactions becomes now feasible and gives new impulse to the use of enabling technologies in the synthesis of 
complex molecules.[5] 
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